Evolus, Inc.
EOLS
Rank in Stocks
#13130
Evolus, Inc. is a performance beauty enterprise that furnishes the United... Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Share Price
$7.37
Last synced: 2026-10-21
Market Cap
$486.46M
Change (1 day)
-0.07%
Change (1 year)
-49.49%
Country
US
Trade Evolus, Inc. (EOLS)
Category
Healthcare
Stock price history for Evolus, Inc. (EOLS)
Highest end of day price: $12.39 on 2025-01-01
Lowest end of day price: $19.84 on 2018-08-01
Lowest end of day price: $19.84 on 2018-08-01
Stock price history of Evolus, Inc. from 2018 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2025 | 3.66% |
| 2024 | 20.62% |
| 2023 | 39.40% |
| 2022 | 15.12% |
| 2021 | -56.66% |
| 2019 | -3.72% |
| 2018 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $160.59 | 20.10% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $211.46 | 23.48% |
CH
|
|
| $18.45 | -3.91% |
IN
|
